COMMUNIQUÉS West-GlobeNewswire

SRx Health Solutions Announces the Cancellation of Approximately 18.8 Million Shares of its Capital Stock
14/08/2025
The Company intends to explore all available legal remedies against former officers of SRx Canada TAMPA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a [...]
Denovo Biopharma LLC to Participate in Upcoming Investor Events
14/08/2025
SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced that company management will participate in upcoming August [...]
SEED Therapeutics Named Finalist for 2025 Prix Galien USA “Best Start-Up” Award
14/08/2025
Nomination recognizes SEED’s pioneering work in molecular glue development in targeted protein degradation to address high unmet medical needs Follows recent FDA IND clearance for SEED’s lead asset RBM39 degrader ST- [...]
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
14/08/2025
PITTSBURGH, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository [...]
Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic
14/08/2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 14, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of [...]
BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
14/08/2025
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), today announced the pricing [...]
Zealand Pharma Announces Financial Results for the First Half of 2025
14/08/2025
Company announcement – No. 18 / 2025 Zealand Pharma Announces Financial Results for the First Half of 2025 Petrelintide collaboration with Roche off to a strong start, while key leadership appointments and solid [...]
Kuros Biosciences Reports First Half of 2025 Results
14/08/2025
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences Reports First Half of 2025 Results Financial Highlights Total Medical Device sales rose by 78% to USD 63.5 million in H1 2025 (H1 [...]
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4
14/08/2025
Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4 Données de l’étude positive de phase 2 évaluant le rilzabrutinib pour le traitement de la maladie liée aux [...]
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
14/08/2025
Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Data from the positive Phase 2 study evaluating rilzabrutinib for the treatment of IgG4-related disease presented at EULAR 2025 [...]
Building Muscle After 50: Why CrazyBulk Muscle Growth & Strength Supplements for Over 50's are Best Sellers in 2025
13/08/2025
New York City, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- In 2025, CrazyBulk is redefining building muscle after 50 by boosting healthy testosterone levels, improving mTOR responsiveness, and enhancing recovery - so men 50+ [...]
Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
13/08/2025
Tevogen.AI to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating [...]
Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results
13/08/2025
Successfully establishes cryptocurrency treasury reserve focused on the HYPE token and becomes the first publicly listed U.S. company to implement DeFi strategies on Hyperliquid blockchain Accumulates more than 1.5 [...]
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
13/08/2025
ROCKVILLE, MD, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company developing innovative antibody-based therapeutics for the treatment of cancer, today [...]
Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress
13/08/2025
Completed Strategic Leadership and Operational Transformation from R&D to Commercial Operations Rebranded as Dyadic Applied BioSolutions to Reflect Our New Operational Priorities Full Redesign of Corporate Website [...]
Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
13/08/2025
Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs, supporting potential for improved protection against infection Enrolled approximately [...]
Glass House Brands Reports Second Quarter 2025 Financial Results
13/08/2025
Results surpassed expectations across key metrics including biomass production, revenue, gross profit, and Adjusted EBITDA Wholesale biomass production was 230,748 pounds, up 54% year-over-year Cost of production was $ [...]
Alumis Reports Second Quarter 2025 Financial Results and Provides Corporate Update
13/08/2025
–Completed enrollment in Phase 3 ONWARD clinical trials for envudeucitinib in moderate-to-severe plaque psoriasis; topline readout expected in early Q1 2026– –Completed enrollment in Phase 2b LUMUS clinical trial for [...]
STRATA Skin Sciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
13/08/2025
HORSHAM, Penn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]

Pages